https://www.nature.com/articles/d41586-025-03855-2 ADHD diagnoses are growing. What’s going on? Helen Pearson In some parts of the world, record numbers of people are being diagnosed with attention deficit hyperactivity disorder (ADHD). In the United States, for example, government researchers last year reported that more than 11% of children had received an ADHD diagnosis at some point in their lives1 — a sharp increase from 2003, when around 8% of children had (see ‘ADHD among US boys and girls’). But now, top US health officials argue that diagnoses have spiralled out of control. In May, the Make America Healthy Again Commission — led by US health secretary Robert F. Kennedy Jr — said ADHD was part of a “crisis of overdiagnosis and overtreatment” and suggested that ADHD medications did not help children in the long term. One thing that’s clear is that several factors — including improved detection and greater awareness of ADHD — are causing people with symptoms to receive a diagnosis and treatment, whereas they wouldn’t have years earlier. Clinicians say this is especially true for women and girls, whose pattern of symptoms was often missed in the past. Although some specialists are concerned about the risks of overdiagnosis, many are more worried that too many people go undiagnosed and untreated. At the same time, the rise in awareness and diagnoses of ADHD has fuelled a public debate about how it should be viewed and how best to provide support, including when medication is required. The emergence of the neurodiversity movement is challenging the view of ADHD as a disorder that should be ‘treated’, and instead proposes that it’s a difference that should be better understood and supported — with more focus on adapting schools and workplaces, for instance. “I do have a big problem with ‘disorder’,” says Jeff Karp, a biomedical engineer at Brigham and Women’s Hospital in Boston, Massachusetts, who has ADHD. “It’s the school system that’s disordered. It’s not the kids.” But many clinicians and people with ADHD argue that it is associated with difficulties — ranging from academic struggles to an increased chance of injuries and substance misuse — that justify its label as a medical condition, and say that medication is an important and effective part of therapy for many people. © 2025 Springer Nature Limited -------------------- https://www.nytimes.com/2025/11/28/health/late-dementia-alzheimers.html Different Type of Dementia Is Changing What’s Known About Cognitive Decline By Pam Belluck A recently recognized form of dementia is changing the understanding of cognitive decline, improving the ability to diagnose patients and underscoring the need for a wider array of treatments. Patients are increasingly being diagnosed with the condition, known as LATE, and guidelines advising doctors how to identify it were published this year. LATE is now estimated to affect about a third of people 85 and older and 10 percent of those 65 and older, according to those guidelines. Some patients who have been told they have Alzheimer’s may actually have LATE, dementia experts say. “In about one out of every five people that come into our clinic, what previously was thought to maybe be Alzheimer’s disease actually appears to be LATE,” said Dr. Greg Jicha, a neurologist and an associate director of the University of Kentucky’s Sanders-Brown Center on Aging. “It can look like Alzheimer’s clinically — they have a memory problem,” Dr. Jicha said. “It looks like a duck, walks like a duck, but then it doesn’t quack, it snorts instead. ” On its own, LATE, shorthand for Limbic-predominant age-related TDP-43 encephalopathy, is usually less severe than Alzheimer’s and unfolds more slowly, said Dr. Pete Nelson, an associate director of the Sanders-Brown Center, who helped galvanize efforts to identify the disorder. That can be reassuring to patients and their families. But there is no specific treatment for LATE. Also, many older people have more than one type of dementia pathology, and when LATE occurs in conjunction with Alzheimer’s, it exacerbates symptoms and speeds decline, he said. © 2025 The New York Times Company -------------------- https://www.science.org/content/article/artificial-nose-tells-people-when-certain-smells-are-present Artificial ‘nose’ tells people when certain smells are present By Catherine Offord Researchers have tested a proof-of-concept device that enabled people who had lost their normal sense of smell to detect the presence of certain odors. Rather than exploiting the smell pathway, in which nasal cells send signals along olfactory nerves to the brain, the technology makes use of a less known nerve highway in the nose that transmits other sensations, including the kick of wasabi and the coolness of mint. “It’s an interesting study,” says Zara Patel, a rhinologist at Stanford Medicine who was not involved in the work, published today in Science Advances. “This is not recovering a sense of smell, this is activating a different system.” But she and others caution it remains to be seen how beneficial this kind of technology could be for people with smell loss, or anosmia. Humans have about 400 different olfactory receptors that are thought to enable the nose to detect billions of odors. But people can lose some or all of their sense of smell for a variety of reasons, including head trauma and viral infections such as COVID-19. People with long-term anosmia describe a significantly reduced quality of life and are at higher risk of mental health disorders, notes Halina Stanley, a research scientist at CNRS, the French national research agency, and co-author on the new paper. “The idea that if you lose your sense of smell, this isn’t as bad as losing another sense, I think is actually quite wrong.” Research by another team in 2018 found that electrodes placed in the sinuses near the olfactory bulb, the brain region that processes odor signals, could stimulate perception of smell, with people reporting onion or fruity scents, for example. Scientists are now working to develop implants that could more directly and specifically stimulate the olfactory bulb—akin to cochlear implants, which replace lost hearing by detecting sounds and stimulating the auditory nerve. However, such technology would be complex and invasive, and, at present, is a long way from becoming a therapy. © 2025 American Association for the Advancement of Science. -------------------- https://www.nytimes.com/2025/11/26/science/paul-ekman-dead.html Paul Ekman, Who Linked Facial Expressions to Universal Emotions, Dies at 91 By Trip Gabriel Paul Ekman, a psychologist who linked thousands of facial expressions to the emotions they often subconsciously conveyed, and who used his research to advise F.B.I. interrogators and screeners for the Transportation Security Administration as well as Hollywood animators, died on Nov. 17 at his home in San Francisco. He was 91. His daughter, Eve Ekman, confirmed the death. Dr. Ekman sought to add scientific exactitude to the human impulse to interpret how others feel through their facial expressions. He recorded 18 types of smiles, for example, distinguishing between a forced smile and a spontaneous one; a genuine smile, he discovered, crinkles the orbicularis oculi muscle — that is, it creates crow’s feet around the eyes. Sometimes described as the world’s most famous face reader, Dr. Ekman was ranked No. 15 in 2015 by the American Psychological Association in its list of 200 eminent psychologists of the modern era. He was influential in reshaping the way facial expressions were understood — as the product of evolution rather than environment — and his findings crossed over to popular culture. The Fox TV drama “Lie to Me,” which ran for three seasons starting in 2009, featured a psychologist modeled on Dr. Ekman (played by Tim Roth) who assists criminal investigations by decoding the hidden meanings of facial expressions and body language. The show was developed by the producer Brian Grazer, who was inspired by a lengthy profile of Dr. Ekman by Malcolm Gladwell in The New Yorker in 2002. “The idea that you could tell a liar by some scientific test and know what they’re feeling just by looking at them was staggering to me,” the show’s writer, Samuel Baum, told The New York Times in 2009. As a young research psychologist in the late 1960s, Dr. Ekman changed the scientific consensus on facial expressions. In the postwar era, the conventional wisdom of eminent anthropologists like Margaret Mead was that human facial expressions were learned and that they varied across cultures. © 2025 The New York Times Company --------------------